Regulatory information - Management of changes to risk management plans and certain quality aspects
New post-authorisation guidance is published today
The European Medicines Agency (EMA) has published today new guidance on the procedural management of risk management plans (RMP) submissions and on the classification of changes to the marketing authorisation post authorisation. Both guidance documents introduce simplified procedures for marketing authorisation holders.
Click on this link for more information.
